Acute undifferentiated leukemia
Clinical trials for Acute undifferentiated leukemia explained in plain language.
Never miss a new study
Get alerted when new Acute undifferentiated leukemia trials appear
Sign up with your email to follow new studies for Acute undifferentiated leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New engineered graft aims to improve stem cell transplants for kids with leukemia
Disease control Recruiting nowThis study tests a specially engineered donor graft called Orca-Q in children and young adults with blood cancers who need a stem cell transplant. The graft is designed to help the new cells take hold and reduce complications. The trial is currently on hold, but aims to enroll 40…
Matched conditions: ACUTE UNDIFFERENTIATED LEUKEMIA
Phase 1/2 • Sponsor: University of Florida • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for babies with leukemia: immunotherapy combo trial launches
Disease control Recruiting nowThis study tests a new treatment plan for infants (up to 12 months old) with a type of leukemia called acute lymphoblastic leukemia. The goal is to see if adding an immunotherapy drug called blinatumomab can better clear leukemia cells that remain after initial treatment. About 9…
Matched conditions: ACUTE UNDIFFERENTIATED LEUKEMIA
Phase 1/2 • Sponsor: Tanja Andrea Gruber • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Supercharged immune cells take on relapsed leukemia
Disease control Recruiting nowThis early-phase trial tests a new immunotherapy for children and adults with acute leukemia that has come back or not responded after a donor stem cell transplant. The treatment uses specially engineered donor T cells designed to recognize and attack a protein called HA-1 found …
Matched conditions: ACUTE UNDIFFERENTIATED LEUKEMIA
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo attack on tough blood cancers: chemo plus transplant shows promise
Disease control Recruiting nowThis study tests a new approach for adults with aggressive blood cancers (like AML) that are likely to return after standard treatment. Participants receive a combination of chemotherapy drugs (decitabine plus FLAG-Ida) and low-dose radiation, followed immediately by a stem cell …
Matched conditions: ACUTE UNDIFFERENTIATED LEUKEMIA
Phase 1/2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for tough leukemia cases: drug combo trial opens for kids and young adults
Disease control Recruiting nowThis study is for children, teens, and young adults (ages 1 to 39) with acute leukemia that has come back or not gotten better with standard treatments. Researchers are testing whether combining two drugs—venetoclax and Vyxeos—is safe and tolerable. The goal is to find the best d…
Matched conditions: ACUTE UNDIFFERENTIATED LEUKEMIA
Phase 1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC